Thursday, March 21, 2019 2:20:28 PM
The MMEX-scam third-party promo crew is stuck with the same desperate, false, unsupportable, and unsupported B.S.
Here’s a clue - posting the same B.S. day after day doesn’t make it true. A lie is a lie.
It's worth repeating: The truth is MMEX-scam...The negative ROI is SIMPLY AMAZING - anyone who invested in MMEX-scam over the last two years likely suffered >97% loss on their “investment.”
The desperate MMEX-scam third-party promotors can’t even get the basics right, from publicly available filings!
MMEX-scam's Dec. 11, 2018 S-3 registration claims 49,274,835 shares outstanding after the offering, and the Mar. 12 10-Q claims 42,283,561 shares outstanding. So there are at least 42.2-million shares outstanding, likely more.
So this claim is 100% false, easily disproven by MMEX-scam's own SEC filings:
MMEX-scam’s financial projections are nothing more than blown-out-the-a-hole fantasy - they are completely false, imaginary, unsupportable B.S.
Who knows what the final projected cost might be for the non-functional Phase I - by now, it will have crossed the $100-million mark. Insolvent OTC share-selling schemes aren’t eligible for $100-million in project financing.
MMEX - You’ve been scammed!
When you are dead, you don't know that you are dead. It is difficult only for others. It is the same when you are stupid.
Recent MMEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:51:51 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/08/2024 02:30:21 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/03/2024 01:18:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 03:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 04:48:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 06:42:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/11/2023 08:50:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/17/2023 08:55:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM